Antipsychotics and Identity: The Adverse Effect No One is Talking About

被引:7
|
作者
Conneely, M. [1 ]
Roe, D. [2 ]
Hasson-Ohayon, I. [2 ]
Pijnenborg, G. H. M. [3 ]
van der Meer, L. [3 ]
Speyer, H. [4 ,5 ]
机构
[1] UCL, Div Psychiat, Maple House, London W1T 7BN, England
[2] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel
[3] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands
[4] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark
[5] Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark
关键词
Antipsychotics; Medication; Neuroleptic Medication; Identity; Self-stigma; Psychosis; Schizophrenia; SHARED DECISION-MAKING; PERSONAL RECOVERY; MEDICATION; EXPERIENCES; PEOPLE; PSYCHOLOGY; ADHERENCE; STIGMA; SELF;
D O I
10.1007/s10597-024-01255-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
People who take antipsychotics, and people who are prescribed antipsychotics without taking them, experience effects which are not frequently discussed: effects on their identity and sense of self. Qualitative research indicates the relationship between taking APs and identity is multilayered, and changeable. Taking APs can restore people to their earlier, pre-symptom sense of self. Being prescribed and taking APs can also, on the other hand, be experienced as damaging, erasing and dulling people's sense of who they are. This complexity deserves exploration in clinical practice, which we believe is currently not done routinely. More work is needed to understand whether, and how, the relationship between identity and APs is being addressed. We outline the importance of having discussions in a clinical space around identity, and a sense of agency, on the grounds that true recovery-oriented care, which enacts shared decision-making principles, demands it. Further, we argue that it will allow for better therapeutic alliance and trust to be forged between clinician and client, ultimately leading to better care.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [21] Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
    Divac, Nevena
    Prostran, Milica
    Jakovcevski, Igor
    Cerovac, Natasa
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [22] Talking about stalking
    Naguy, Ahmed
    Alhumoud, Abdulmohsen
    ANNALES MEDICO-PSYCHOLOGIQUES, 2021, 179 (02): : 186 - 191
  • [23] Association between antipsychotics and cardiovascular adverse events: A systematic review
    Santos da Silva, Ana Amancio
    Moura Rezende Ribeiro, Marina Viegas
    de Sousa-Rodrigues, Celio Fernando
    Barbosa, Fabiano Timbo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (03): : 261 - 267
  • [24] The Seductions of Identity: Thinking About Identity and Transgender
    Lemma, Alessandra
    PSYCHOANALYTIC QUARTERLY, 2023, 92 (03) : 407 - 434
  • [25] Characteristics of voluntary reporting of adverse drug events related to antipsychotics in Australia: 14-year analysis
    Khalil, Hanan
    Hoppe, Dimi
    Ameen, Nabil
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [26] Cognition, schizophrenia and the effect of antipsychotics
    Stip, E.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2006, 32 (03): : 341 - 350
  • [27] Talking About It: Stories as Paths to Healing After Violence
    Pasupathi, Monisha
    Fivush, Robyn
    Hernandez-Martinez, Martha
    PSYCHOLOGY OF VIOLENCE, 2016, 6 (01) : 49 - 56
  • [28] Talking About Sexuality With Consumers of Mental Health Services
    Quinn, Chris
    Happell, Brenda
    PERSPECTIVES IN PSYCHIATRIC CARE, 2013, 49 (01) : 13 - 20
  • [29] Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia
    Yoshida, Kazunari
    Takeuchi, Hiroyoshi
    BEHAVIOURAL BRAIN RESEARCH, 2021, 402
  • [30] Neurological Adverse Effects of Antipsychotics in Children and Adolescents
    Garcia-Amador, Margarita
    Merchan-Naranjo, Jessica
    Tapia, Cecilia
    Moreno, Carmen
    Castro-Fornieles, Josefina
    Baeza, Inmaculada
    de la Serna, Elena
    Alda, Jose A.
    Munoz, Daniel
    Andres Nestares, Patricia
    Martinez Cantarero, Carmen
    Arango, Celso
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (06) : 686 - 693